At a glance
- Originator Guangdong Taihe Pharmaceutical; Sun Yat-Sen University
- Class Anti-ischaemics; Ginsenosides; Saponins
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for clinical-Phase-Unknown development in Stroke in China (IV)
- 26 Nov 2015 Clinical trials in Stroke in China (IV)